Stem cell therapies, regenerative medicine, tissue engineering, and cellular reprogramming
188 Artikel
Xenotransplantation, 3D-Biodruck und Stammzelltherapien konvergieren, um die globale Krise des Organmangels zu lösen.
NIDCR-Forscher verglichen Stromazellen aus Knochenmark, Haut, Milz und Fettgewebe, um festzustellen, welche am besten zur Knochenregeneration und Blutbildung beiträgt.
Scientists engineer high-PS procoagulant platelets that outperform thrombin and commercial hemostatic agents, even in antiplatelet-treated patients.
Harvard researchers identify a rare mesenchymal cell type that regenerates the thymus and boosts T cell immunity in aged animals.
Kyoto researchers built the first fully in vitro system that guides stem cells through every stage of human thymus development, producing functional T cells.
Computational protein design produces potent GPCR-targeting miniproteins for pain, cancer, obesity, and migraine with in vivo efficacy.
A phase 2b trial finds allogeneic MSC infusions improved 6-minute walk distance by 63 meters vs placebo at 9 months in frail older adults.
Cytosine base editing achieved 62–89% efficiency fixing a hyperinflammatory disease gene, but revealed distinct genotoxicity risks across cell types.
A special issue overview surveys three decades of peptide-based materials research, spotlighting applications from drug delivery to regenerative medicine.
A landmark clinical trial transplanted iPSC-derived dopamine neurons into Parkinson's patients using only tacrolimus — with no significant immune rejection.
Researchers 3D-printed silicone scaffolds seeded with human iPSC-derived spinal neural progenitor cells, transplanted them into transected rat spinal cords, and observed significant functional recovery at 12 weeks.
Meistern Sie die hochmoderne Wissenschaft der Exosomen-Entwicklung, Pharmakokinetiik der Wirkstofffreisetzung und klinischen Translation – von CRISPR-beladenen Nanopartikeln bis zur molekularen Logik der Regenerativtherapien der nächsten Generation.
